Skip to main content
SpringerLink
Log in

Combined Antidepressant Strategies Are Not More Effective Than Vigorous Escitalopram Monotherapy: Results of the CO-MED Study

  • Clinical Trial Report
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatr. 2006;163:28–40.

    Article  PubMed  Google Scholar 

  2. Kennedy SH, Young AH, Blier P. Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets. J Affect Disord. 2011;132 Suppl 1:S21–8.

    Article  PubMed  Google Scholar 

  3. Thase ME. Antidepressant combinations: widely used, but far from empirically validated. Can J Psychiatr. 2011;56:317–23.

    Google Scholar 

  4. Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, et al. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. Eur Neuropsychopharmacol. 2009;19:457–65.

    Article  PubMed  CAS  Google Scholar 

  5. Blier P, Ward HE, Tremblay P, Laberge L, Hébert C, Bergeron R. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatr. 2010;167:281–8.

    Article  PubMed  Google Scholar 

  6. Coryell W. The search for improved antidepressant strategies: is bigger better? Am J Psychiatr. 2011;168:664–6.

    Article  PubMed  Google Scholar 

  7. Nelson JC, Mazure CM, Jatlow PI, Bowers Jr MB, Price LH. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biol Psychiatr. 2004;55:296–300.

    Article  CAS  Google Scholar 

  8. Thase ME. Managing depressive and anxiety disorders with escitalopram. Expert Opin Pharmacother. 2006;7(4):429–40.

    Article  PubMed  CAS  Google Scholar 

  9. Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatr. 2009;166:980–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA

    Michael E. Thase

  2. University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Michael E. Thase

  3. Perelman School of Medicine of the University of Pennsylvania, 3535 Market Street, Suite 670, Philadelphia, PA, 19104, USA

    Michael E. Thase

Authors
  1. Michael E. Thase
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael E. Thase.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thase, M.E. Combined Antidepressant Strategies Are Not More Effective Than Vigorous Escitalopram Monotherapy: Results of the CO-MED Study. Curr Psychiatry Rep 13, 434–436 (2011). https://doi.org/10.1007/s11920-011-0236-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-011-0236-9

Keywords

Search

Navigation